HCA Healthcare (HCA) Now Covered by Stephens

Share on StockTwits

Analysts at Stephens initiated coverage on shares of HCA Healthcare (NYSE:HCA) in a research report issued to clients and investors on Monday, The Fly reports. The firm set an “overweight” rating on the stock.

A number of other analysts have also issued reports on HCA. Bank of America boosted their target price on HCA Healthcare from $125.00 to $135.00 and gave the company an “underperform” rating in a research report on Tuesday, September 18th. Robert W. Baird boosted their target price on HCA Healthcare from $130.00 to $150.00 and gave the company a “positive” rating in a research report on Thursday, September 20th. Jefferies Financial Group boosted their target price on HCA Healthcare to $155.00 and gave the company a “buy” rating in a research report on Friday, September 21st. Citigroup boosted their target price on HCA Healthcare from $136.00 to $156.00 and gave the company a “buy” rating in a research report on Thursday, October 11th. Finally, Credit Suisse Group boosted their target price on HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research report on Thursday, November 1st. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare presently has a consensus rating of “Buy” and a consensus price target of $143.14.

HCA opened at $129.14 on Monday. HCA Healthcare has a one year low of $86.72 and a one year high of $147.42. The company has a market capitalization of $44.16 billion, a P/E ratio of 19.60, a price-to-earnings-growth ratio of 1.04 and a beta of 0.69.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.23. The company had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.13 earnings per share. Equities analysts anticipate that HCA Healthcare will post 9.33 EPS for the current fiscal year.

In related news, SVP Deborah M. Reiner sold 723 shares of the business’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the transaction, the senior vice president now owns 6,184 shares in the company, valued at $835,211.04. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 820 shares of the business’s stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now owns 4,237 shares of the company’s stock, valued at approximately $603,179.32. The disclosure for this sale can be found here. In the last quarter, insiders have sold 16,763 shares of company stock valued at $2,346,147. Insiders own 2.80% of the company’s stock.

Several hedge funds have recently modified their holdings of HCA. Panagora Asset Management Inc. boosted its stake in shares of HCA Healthcare by 44.0% during the third quarter. Panagora Asset Management Inc. now owns 36,733 shares of the company’s stock worth $5,110,000 after buying an additional 11,216 shares during the period. WINTON GROUP Ltd raised its holdings in HCA Healthcare by 3,350.7% during the third quarter. WINTON GROUP Ltd now owns 205,078 shares of the company’s stock worth $28,530,000 after purchasing an additional 199,135 shares in the last quarter. C WorldWide Group Holding A S raised its holdings in HCA Healthcare by 16.6% during the third quarter. C WorldWide Group Holding A S now owns 92,727 shares of the company’s stock worth $12,900,000 after purchasing an additional 13,192 shares in the last quarter. FMR LLC raised its holdings in HCA Healthcare by 54.9% during the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after purchasing an additional 1,944,961 shares in the last quarter. Finally, Aperio Group LLC raised its holdings in HCA Healthcare by 7.5% during the third quarter. Aperio Group LLC now owns 224,614 shares of the company’s stock worth $31,248,000 after purchasing an additional 15,680 shares in the last quarter. Hedge funds and other institutional investors own 69.82% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Blue-Chip Stocks

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply